PharmCADD

Kenya
Kasuku, Nyandarua County, Kenya

Company profile

PharmCADD company profile

PharmCADD develops a new drug development platform that uses AI-based protein structure prediction algorithms, MD simulation, and quantum calculation to enable faster drug design. PharmCADD's products include Pharmulator, a consolidated drug discovery platform comprised of five core modules such as protein/RNA 3D structure prediction, drug generation, virtual screening, quantum calculation, and toxicity prediction to generate candidates with higher potential; and PharmVAC, a vaccine development platform that provides optimal solutions to users and clients to design, analyze, and visualize more probable RNA sequences for any vaccine candidates.

Business identity

Operating status
Active
Company type
For Profit
Employee range
51-100 employees
Revenue range
$1M-$10M
Founded
2019-03-05

Headquarters

Country code
KE
Continent
Africa

Capital profile

Funding and company signals

Funding stage
Early Stage Venture
Funding rounds
4
Total equity funding
$19.8M
Last funding
Series B / $16M / 2021-04-19
Last equity funding
Series B / $16M
Investors
10
Lead investors
4
Founders
1
Articles
4

Founders and investors

Founders

Taehyung Kwon

Lead investors

DAOL InvestmentDayli PartnersDt& InvestmentSD Group

Investors

Dayli PartnersDSC InvestmentHuonsKB SecuritiesKDB Capital